NCT00024466View on ClinicalTrials.gov

Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

December 31, 2004

Study Completion Date

April 30, 2009

Conditions
Multiple Myeloma
Interventions
BIOLOGICAL

GVAX

PROCEDURE

Autologous transplant

Trial Locations (1)

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00024466 - Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma | Biotech Hunter | Biotech Hunter